Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002419102 | SCV002678595 | uncertain significance | Cardiovascular phenotype | 2021-09-13 | criteria provided, single submitter | clinical testing | The p.L2666Q variant (also known as c.7997T>A), located in coding exon 53 of the RYR2 gene, results from a T to A substitution at nucleotide position 7997. The leucine at codon 2666 is replaced by glutamine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |